211 related articles for article (PubMed ID: 38273368)
1. New insight into the intravenous immunoglobulin treatment in Multisystem Inflammatory Syndrome in children and adults.
Chen CJ; Kao HY; Huang CH; Li CJ; Hung CH; Yong SB
Ital J Pediatr; 2024 Jan; 50(1):18. PubMed ID: 38273368
[TBL] [Abstract][Full Text] [Related]
2. Treatment of multisystem inflammatory syndrome in children.
Tong T; Jin YH; Wang M; Gong FQ
World J Pediatr; 2024 Apr; 20(4):325-339. PubMed ID: 38509432
[TBL] [Abstract][Full Text] [Related]
3. An Insight into Multisystem Inflammatory Syndrome in Adults Associated with Recent SARS-COV-2 Infection: A Case Series.
Agarwal A; Jakhar R; Sharma A; Sharma A; Agarwal A; Kumari A
J Assoc Physicians India; 2023 Aug; 71(8):11-12. PubMed ID: 37651238
[TBL] [Abstract][Full Text] [Related]
4. Infliximab treatment for refractory COVID-19-associated multisystem inflammatory syndrome in a Japanese child.
Yamaguchi Y; Takasawa K; Irabu H; Hiratoko K; Ichigi Y; Hirata K; Tamura Y; Murakoshi M; Yamashita M; Nakatani H; Shimoda M; Ishii T; Udagawa T; Shimizu M; Kanegane H; Morio T
J Infect Chemother; 2022 Jun; 28(6):814-818. PubMed ID: 35125343
[TBL] [Abstract][Full Text] [Related]
5. Association of Intravenous Immunoglobulins Plus Methylprednisolone vs Immunoglobulins Alone With Course of Fever in Multisystem Inflammatory Syndrome in Children.
Ouldali N; Toubiana J; Antona D; Javouhey E; Madhi F; Lorrot M; Léger PL; Galeotti C; Claude C; Wiedemann A; Lachaume N; Ovaert C; Dumortier M; Kahn JE; Mandelcwajg A; Percheron L; Biot B; Bordet J; Girardin ML; Yang DD; Grimaud M; Oualha M; Allali S; Bajolle F; Beyler C; Meinzer U; Levy M; Paulet AM; Levy C; Cohen R; Belot A; Angoulvant F;
JAMA; 2021 Mar; 325(9):855-864. PubMed ID: 33523115
[TBL] [Abstract][Full Text] [Related]
6. Similarities and differences between multiple inflammatory syndrome in children associated with COVID-19 and Kawasaki disease: clinical presentations, diagnosis, and treatment.
Zhang QY; Xu BW; Du JB
World J Pediatr; 2021 Aug; 17(4):335-340. PubMed ID: 34013488
[TBL] [Abstract][Full Text] [Related]
7. Phenotype, Susceptibility, Autoimmunity, and Immunotherapy Between Kawasaki Disease and Coronavirus Disease-19 Associated Multisystem Inflammatory Syndrome in Children.
Chen MR; Kuo HC; Lee YJ; Chi H; Li SC; Lee HC; Yang KD
Front Immunol; 2021; 12():632890. PubMed ID: 33732254
[TBL] [Abstract][Full Text] [Related]
8. [Clinical analysis of 11 cases multisystem inflammatory syndrome associated with SARS-CoV-2 Omicron variant infection in children].
Zhang HS; Chang XT; Wu PH; Song DY; Ge G; Ding W; Hu ZW; Wang GF; Jiang YW; Ye LP
Zhonghua Er Ke Za Zhi; 2024 Jan; 62(1):55-59. PubMed ID: 38154978
[No Abstract] [Full Text] [Related]
9. Early combination therapy with immunoglobulin and steroids is associated with shorter ICU length of stay in Multisystem Inflammatory Syndrome in Children (MIS-C) associated with COVID-19: A retrospective cohort analysis from 28 U.S. Hospitals.
Harthan AA; Nadiger M; McGarvey JS; Hanson K; Gharpure VP; Bjornstad EC; Chiotos K; Miller AS; Reikoff RA; Gajic O; Kumar V; Walkey AJ; Kashyap R; Tripathi S;
Pharmacotherapy; 2022 Jul; 42(7):529-539. PubMed ID: 35661394
[TBL] [Abstract][Full Text] [Related]
10. SARS-CoV-2-associated multisystem inflammatory syndrome in children: clinical manifestations and the role of infliximab treatment.
Abdel-Haq N; Asmar BI; Deza Leon MP; McGrath EJ; Arora HS; Cashen K; Tilford B; Charaf Eddine A; Sethuraman U; Ang JY
Eur J Pediatr; 2021 May; 180(5):1581-1591. PubMed ID: 33452570
[TBL] [Abstract][Full Text] [Related]
11. Severe COVID-19, multisystem inflammatory syndrome in children, and Kawasaki disease: immunological mechanisms, clinical manifestations and management.
Kabeerdoss J; Pilania RK; Karkhele R; Kumar TS; Danda D; Singh S
Rheumatol Int; 2021 Jan; 41(1):19-32. PubMed ID: 33219837
[TBL] [Abstract][Full Text] [Related]
12. Pathogenesis, immunology, and immune-targeted management of the multisystem inflammatory syndrome in children (MIS-C) or pediatric inflammatory multisystem syndrome (PIMS): EAACI Position Paper.
Feleszko W; Okarska-Napierała M; Buddingh EP; Bloomfield M; Sediva A; Bautista-Rodriguez C; Brough HA; Eigenmann PA; Eiwegger T; Eljaszewicz A; Eyerich S; Gomez-Casado C; Fraisse A; Janda J; Jiménez-Saiz R; Kallinich T; Krohn IK; Mortz CG; Riggioni C; Sastre J; Sokolowska M; Strzelczyk Z; Untersmayr E; Tramper-Stranders G;
Pediatr Allergy Immunol; 2023 Jan; 34(1):e13900. PubMed ID: 36705045
[TBL] [Abstract][Full Text] [Related]
13. Multiple system inflammatory syndrome associated with SARS-CoV-2 infection in an adult and an adolescent.
Bastug A; Aslaner H; Aybar Bilir Y; Kemirtlek N; Gursoy FM; Bastug S; Bodur H
Rheumatol Int; 2021 May; 41(5):993-1008. PubMed ID: 33742229
[TBL] [Abstract][Full Text] [Related]
14. Safety and efficacy of pharmacological approaches available for multisystem inflammatory syndrome in children (MIS-C): a systematic review.
Velusamy Y; Vivekanandan G; Romli MH; Shankar A; Karuppiah T; Yubbu P
Turk J Pediatr; 2023; 65(5):719-738. PubMed ID: 37853964
[TBL] [Abstract][Full Text] [Related]
15. Multisystem Inflammatory Syndrome in Children - Initial Therapy and Outcomes.
Son MBF; Murray N; Friedman K; Young CC; Newhams MM; Feldstein LR; Loftis LL; Tarquinio KM; Singh AR; Heidemann SM; Soma VL; Riggs BJ; Fitzgerald JC; Kong M; Doymaz S; Giuliano JS; Keenaghan MA; Hume JR; Hobbs CV; Schuster JE; Clouser KN; Hall MW; Smith LS; Horwitz SM; Schwartz SP; Irby K; Bradford TT; Maddux AB; Babbitt CJ; Rowan CM; McLaughlin GE; Yager PH; Maamari M; Mack EH; Carroll CL; Montgomery VL; Halasa NB; Cvijanovich NZ; Coates BM; Rose CE; Newburger JW; Patel MM; Randolph AG;
N Engl J Med; 2021 Jul; 385(1):23-34. PubMed ID: 34133855
[TBL] [Abstract][Full Text] [Related]
16. Treatment of Multisystem Inflammatory Syndrome in Children.
McArdle AJ; Vito O; Patel H; Seaby EG; Shah P; Wilson C; Broderick C; Nijman R; Tremoulet AH; Munblit D; Ulloa-Gutierrez R; Carter MJ; De T; Hoggart C; Whittaker E; Herberg JA; Kaforou M; Cunnington AJ; Levin M;
N Engl J Med; 2021 Jul; 385(1):11-22. PubMed ID: 34133854
[TBL] [Abstract][Full Text] [Related]
17. Trends in Treatments for Multisystem Inflammatory Syndrome in Children (MIS-C), United States, February 2020 - July 2021.
Abrams JY; Belay ED; Godfred-Cato S; Campbell AP; Zambrano LD; Kunkel A; Miller AD; Wu MJ; Meng L; Shah AB; Oster ME
Clin Infect Dis; 2022 Sep; 75(7):1201-1209. PubMed ID: 35100610
[TBL] [Abstract][Full Text] [Related]
18. Clinico-Laboratory Profile, Intensive Care Needs and Short-Term Outcome of Multisystem Inflammatory Syndrome in Children (MIS-C): Experience during First and Second Waves from North India.
Angurana SK; Kumar V; Nallasamy K; Kumar MR; Naganur S; Kumar M; Goyal K; Ghosh A; Bansal A; Jayashree M
J Trop Pediatr; 2022 Aug; 68(5):. PubMed ID: 36048462
[TBL] [Abstract][Full Text] [Related]
19. A retrospective comparative analysis of factors affecting the decision and outcome of initial intravenous immunoglobulin alone or intravenous immunoglobulin plus methylprednisolone use in children with the multisystem inflammatory syndrome.
Devrim İ; Böncüoğlu E; Kıymet E; Şahinkaya Ş; Çelebi MY; Cem E; Düzgöl M; Arıkan KÖ; Kara AA; Besin D; Vuran G; Seven P; Meşe T; Ağın H; Bayram N
Pediatr Rheumatol Online J; 2022 Aug; 20(1):69. PubMed ID: 35987681
[TBL] [Abstract][Full Text] [Related]
20. Management skin manifestation of multisystem inflammatory syndrome associated with SARS-CoV-2.
Bayram YE; Yildiz-Sevgi D; Yavuz A; Cancetin M; Gurler MY
Virol J; 2022 Jan; 19(1):9. PubMed ID: 34991644
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
